Here’s another installment of PubPeer Selections: Continue reading PubPeer Selections: More stem cell questions; “is the hassle of a correction really needed?”
Author: Ivan Oransky
Authors retract green coffee bean diet paper touted by Dr. Oz
Two authors of a 2012 paper sponsored by a company that made grand claims about green coffee bean extract’s abilities to help people lose weight have retracted it. The study was cited by The Dr. Oz Show, and last month it cost the company a $3.5 million settlement with the Feds.
Here’s the notice for “Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects,” a paper originally published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy: Continue reading Authors retract green coffee bean diet paper touted by Dr. Oz
Weekend reads: “Too good to be true” results; the paper as an “artificial landmark”
The week at Retraction Watch kicked off with news of the European Science Foundation threatening to sue a scientist for calling a review process “flawed.” Here’s what was happening elsewhere:
Continue reading Weekend reads: “Too good to be true” results; the paper as an “artificial landmark”
At a snail’s pace: Species rediscovered, but paper on its disappearance remains
A few weeks ago, in Weekend Reads, we highlighted the story of a snail species, thought to have gone extinct thanks to global warming, that had been rediscovered.
Now, as first reported by The Scientist, the journal in question has addressed the issue.
Here’s the story: In 2007, Biology Letters published a paper by Justin Gerlach describing the extinction of the Aldabra banded snail. But as journal editor Richard Battarbee notes: Continue reading At a snail’s pace: Species rediscovered, but paper on its disappearance remains
Neuroscientist who threatened to sue Science-Fraud.org, retracted two papers is out at Tufts
Gizem Donmez, a neuroscientist who has retracted two papers from Cell and the Journal of Biological Chemistry, is no longer in her position at Tufts University, Retraction Watch has learned.
A Tufts spokesperson confirmed the news for us yesterday: Continue reading Neuroscientist who threatened to sue Science-Fraud.org, retracted two papers is out at Tufts
PubPeer Selections: PubPeer comments lead to Science correction; crystal structure in triplicate
European Science Foundation demands retraction of criticism in Nature, threatens legal action
The European Science Foundation (ESF) has threatened legal action against a scientist for calling an evaluation process supported by the agency “flawed” in a commentary piece in Nature.
Amaya Moro-Martin, an assistant astronomer at the Space Telescope Science Institute (STScI) and an associate research scientist at The Johns Hopkins University, apparently angered the ESF with the bolded phrase below: Continue reading European Science Foundation demands retraction of criticism in Nature, threatens legal action
Weekend reads: Senator loses degree for plagiarism; bad colitis poetry; fraud on the big screen
The week at Retraction Watch featured papers by a fake author with a brilliant if profane name, and the unmasking of fraudster Diederik Stapel as a sock puppet. Here’s what was happening elsewhere: Continue reading Weekend reads: Senator loses degree for plagiarism; bad colitis poetry; fraud on the big screen
After 16 retractions, management professor Lichtenthaler resigns post
Ulrich Lichtenthaler, a management professor at the University of Mannheim who has had to retract 16 papers for data irregularities, has resigned his faculty position.
According to a terse release from the university (translated from German): Continue reading After 16 retractions, management professor Lichtenthaler resigns post
Yet another study of widely touted cancer “cure” retracted
A third study of GcMAF, a protein being used to treat a variety of conditions from AIDS to autism to cancer, all without the blessing of health agencies, has been retracted.
Here’s the notice in Cancer Immunology, Immunotherapy for “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF:” Continue reading Yet another study of widely touted cancer “cure” retracted